Testosterone is a steroid sex hormone indicated to treat primary hypogonadism and hypogonadotropic hypogonadism. Testosterone antagonizes the androgen receptor to induce gene expression that causes the growth and development of masculine sex organs and secondary sexual characteristics.
Testosterone was isolated from samples and also synthesized in 1935.
Testosterone is indicated to treat primary hypogonadism and hypogonadotropic hypogonadism.
Herlev University Hospital, Herlev, Denmark
Copenhagen University Hospital, Copenhagen, Denmark
Zealand University Hospital, Roskilde, Denmark
Endo Clinical Trial Site #22, Tucson, Arizona, United States
Endo Clinical Trial Site #3, Oviedo, Florida, United States
Endo Clinical Trial Site #27, Glen Burnie, Maryland, United States
Instituto de Investigación Materno Infantil (IDIMI) - Maternidad Hospital San Borja (HCSBA), Santiago, Chile
University of Colorado Hospital, Aurora, Colorado, United States
University Medical Center Ljubljana, Ljubljana, Slovenia
Children's Hospital Colorado, Aurora, Colorado, United States
University of Miami, Miami, Florida, United States
Innovative Research of West Florida, Inc., Clearwater, Florida, United States
Primary Care Research Group, Atlanta, Georgia, United States
National Clinical Research, Inc., Richmond, Virginia, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.